In the present study, we first investigated the ability and mechanism of PM to reduce the degree of AngII‐induced cardiomyocyte hypertrophy in vitro and TAC‐induced cardiac hypertrophy in vivo. This evidence concerns the gene AGT and cardiac hypertrophy.